Both in Surgical Instruments
Carlsmed vs Embecta
Over the past year CARL returned +17.8% and EMBC returned −54.7%; their daily moves had a correlation of 0.14.
CARL +17.8% EMBC −54.7%Growth of $1, one year, split-adjusted
| Metric | CARL | EMBC |
|---|---|---|
| Price | $14.40 | $6.08 |
| Market cap | $393.2M | $344.5M |
| Today | −4.13% | −1.78% |
| 1 month | −5.9% | +3.4% |
| 6 months | +61.4% | +55.9% |
| Year to date | +16.6% | −48.8% |
| 1 year | +11.7% | −54.4% |
| Revenue growth (YoY) | — | −8.1% |
| Gross margin | 76.8% | 56.4% |
| Net margin | −55.5% | 7.8% |
| P/E (TTM) | — | 3.9× |
| Price / sales | 6.2× | 0.3× |
| Net cash | $73.8M | -$1.27B |
| Dividend yield | — | 0.66% |
| Volatility (60d) | 47.7% | 51.5% |
| Short % of float | 11.3% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).